| Ms Emilie R Torretta, CNM | |
|
2205 W Lincoln Ave, Yakima, WA 98902-2437 | |
| (509) 575-1990 | |
| Not Available |
| Full Name | Ms Emilie R Torretta |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 2205 W Lincoln Ave, Yakima, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033414784 | NPI | - | NPPES |
| 2011358 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN00134861 (Washington) | Secondary |
| 367A00000X | Advanced Practice Midwife | AP60188562 (Washington) | Primary |
| Entity Name | Kittitas County Public Hospital Dist 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356375307 PECOS PAC ID: 0547179608 Enrollment ID: O20040213000046 |
News Archive
Prednisone and non-steroidal anti-inflammatory drugs (NSAIDs) can be used for symptom control, but to prevent joint damage, we use disease-modifying anti-rheumatic drugs (DMARDs) including the cornerstone, methotrexate.
Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.
The American Health Assistance Foundation, a nonprofit organization with a history of funding breakthrough research on age-related vision diseases, announced today that it has awarded 21 new grants totaling $2.1 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible blindness in the world.
Dynasil Corporation of America today announced that the U.S. Department of Energy (DOE) has approved seven of its Phase-II SBIR projects for awards, ranging from $750,000 to $1,000,000 each. The awards, totaling $6.2 million, are being made to its wholly owned subsidiary, Radiation Monitoring Devices, Inc, to develop its state of the art nuclear sensors and instruments.
› Verified 8 days ago
| Entity Name | Valley Medical Group-renton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619209574 PECOS PAC ID: 4183753965 Enrollment ID: O20100604000113 |
News Archive
Prednisone and non-steroidal anti-inflammatory drugs (NSAIDs) can be used for symptom control, but to prevent joint damage, we use disease-modifying anti-rheumatic drugs (DMARDs) including the cornerstone, methotrexate.
Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.
The American Health Assistance Foundation, a nonprofit organization with a history of funding breakthrough research on age-related vision diseases, announced today that it has awarded 21 new grants totaling $2.1 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible blindness in the world.
Dynasil Corporation of America today announced that the U.S. Department of Energy (DOE) has approved seven of its Phase-II SBIR projects for awards, ranging from $750,000 to $1,000,000 each. The awards, totaling $6.2 million, are being made to its wholly owned subsidiary, Radiation Monitoring Devices, Inc, to develop its state of the art nuclear sensors and instruments.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Emilie R Torretta, CNM Po Box 190, Toppenish, WA 98948-0190 Ph: (509) 865-6175 | Ms Emilie R Torretta, CNM 2205 W Lincoln Ave, Yakima, WA 98902-2437 Ph: (509) 575-1990 |
News Archive
Prednisone and non-steroidal anti-inflammatory drugs (NSAIDs) can be used for symptom control, but to prevent joint damage, we use disease-modifying anti-rheumatic drugs (DMARDs) including the cornerstone, methotrexate.
Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses.
The American Health Assistance Foundation, a nonprofit organization with a history of funding breakthrough research on age-related vision diseases, announced today that it has awarded 21 new grants totaling $2.1 million to scientists worldwide who are studying glaucoma and macular degeneration. The two conditions are the leading causes of irreversible blindness in the world.
Dynasil Corporation of America today announced that the U.S. Department of Energy (DOE) has approved seven of its Phase-II SBIR projects for awards, ranging from $750,000 to $1,000,000 each. The awards, totaling $6.2 million, are being made to its wholly owned subsidiary, Radiation Monitoring Devices, Inc, to develop its state of the art nuclear sensors and instruments.
› Verified 8 days ago
Nicole Marie Weiss, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1117 Tieton Dr, Yakima, WA 98902 Phone: 866-904-7721 | |
Tamara Baker, ARNP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2205 W Lincoln Ave, Yakima, WA 98902 Phone: 509-575-3399 Fax: 509-575-3397 | |
Courtney Marie Mundy, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1510 W Yakima Ave, Yakima, WA 98902 Phone: 509-367-7158 Fax: 509-453-1400 | |
Judy Stewart, ARNP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2205 W Lincoln Ave, Yakima, WA 98902 Phone: 590-575-1234 Fax: 509-575-3320 |